AICPI
ABG Innovation Capital Partners III Portfolio holdings
AUM
$49.9K
This Quarter Return
-7.71%
1 Year Return
+0.25%
3 Year Return
-18.22%
5 Year Return
–
10 Year Return
–
AUM
$2.41M
AUM Growth
+$2.41M
(-92%)
Cap. Flow
-$38.1M
Cap. Flow
% of AUM
-1,584.89%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Atea Pharmaceuticals
AVIR
|
$27.2M |
| 2 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$11M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WHWK
1
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $783K | 32.53% | 26,666 -373,334 | -93% | -$11M |
|
|
GNCA
2
DELISTED
Genocea Biosciences, Inc.
GNCA
| $720K | 29.91% | 375,000 | – | – |
|
3
Synlogic
SYBX
$17M
| $628K | 26.09% | 205,906 | – | – |
|
4
Pulmonx
LUNG
$69.7M
| $163K | 6.77% | 4,521 | – | – |
|
|
ACGN
5
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $58K | 2.41% | 56,250 | – | – |
|
|
NBRV
6
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $55K | 2.29% | 45,849 | – | – |
|
|
7
Atea Pharmaceuticals
AVIR
$267M
| – | – | -1,265,631 | Closed | -$27.2M |
|